[Multidisciplinary tailoring of therapy of metastatic colon cancer]

Duodecim. 2016;132(12):1177-84.
[Article in Finnish]

Abstract

Treatment of colon cancer requires multidisciplinary team work. The multitude of therapies in metastatic colon cancer have led to longer overall survival with fewer symptoms. Median survival has increased from 5 months with the best supportive care to 30-40 months in randomized studies, even with curative treatment in some patients. Tailoring of the treatment is best done by a multidisciplinary team considering radiotherapy and operation of the primary tumor, resection of liver, lung and peritoneal metastases, medical treatment alternatives, palliative care, ablative methods etc. Without skillful surgeons, oncologists, pathologists, geneticists, radiologists etc. the best treatment opportunities may be missed.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Colonic Neoplasms / pathology
  • Colonic Neoplasms / therapy*
  • Combined Modality Therapy
  • Humans
  • Patient Care Team / organization & administration*
  • Survival Analysis